Tower Research Capital LLC (Trc) Rhythm Pharmaceuticals, Inc. Transaction History

Tower Research Capital LLC (Trc)

$3.68 Billion
Q3 2024

A detailed history of Tower Research Capital LLC (Trc) transactions in Rhythm Pharmaceuticals, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 378 shares of RYTM stock, worth $22,370. This represents 0.0% of its overall portfolio holdings.

Number of Shares

378

Previous 9,925 96.19%

Holding current value

$22,370

Previous $407,000 95.33%

% of portfolio

0.0%

Previous 0.01%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$40.81 - $55.0 $389,613 - $525,085	-9,547 Reduced 96.19%	378 $19,000
Q2 2024 Aug 13, 2024	BUY	$35.41 - $44.37 $332,358 - $416,456	9,386 Added 1741.37%	9,925 $407,000
Q1 2024 May 15, 2024	SELL	$39.12 - $52.44 $358,691 - $480,822	-9,169 Reduced 94.45%	539 $23,000
Q4 2023 Feb 13, 2024	BUY	$21.39 - $49.64 $187,461 - $435,044	8,764 Added 928.39%	9,708 $446,000
Q3 2023 Nov 14, 2023	SELL	$15.81 - $27.8 $44,362 - $78,006	-2,806 Reduced 74.83%	944 $21,000
Q2 2023 Aug 14, 2023	SELL	$16.32 - $21.15 $219,716 - $284,742	-13,463 Reduced 78.21%	3,750 $61,000
Q1 2023 May 09, 2023	BUY	$16.88 - $34.24 $58,455 - $118,573	3,463 Added 25.19%	17,213 $307,000
Q4 2022 Feb 10, 2023	BUY	$22.21 - $30.25 $117,179 - $159,599	5,276 Added 62.26%	13,750 $400,000
Q3 2022 Nov 10, 2022	BUY	$4.3 - $30.85 $11,481 - $82,369	2,670 Added 46.0%	8,474 $207,000
Q2 2022 Aug 15, 2022	SELL	$3.12 - $12.25 $89,556 - $351,624	-28,704 Reduced 83.18%	5,804 $25,000
Q1 2022 May 12, 2022	BUY	$6.13 - $12.24 $196,098 - $391,557	31,990 Added 1270.45%	34,508 $397,000
Q4 2021 Feb 14, 2022	SELL	$8.62 - $13.9 $5,852 - $9,438	-679 Reduced 21.24%	2,518 $25,000
Q3 2021 Nov 15, 2021	SELL	$11.68 - $20.72 $6,283 - $11,147	-538 Reduced 14.4%	3,197 $41,000
Q2 2021 Aug 16, 2021	BUY	$18.52 - $22.55 $27,057 - $32,945	1,461 Added 64.25%	3,735 $73,000
Q1 2021 May 17, 2021	BUY	$20.25 - $39.49 $30,172 - $58,840	1,490 Added 190.05%	2,274 $48,000
Q4 2020 Feb 16, 2021	SELL	$21.17 - $32.61 $26,102 - $40,208	-1,233 Reduced 61.13%	784 $23,000
Q3 2020 Nov 16, 2020	SELL	$18.13 - $30.61 $13,905 - $23,477	-767 Reduced 27.55%	2,017 $44,000
Q2 2020 Aug 13, 2020	BUY	$14.41 - $25.35 $40,117 - $70,574	2,784 New	2,784 $62,000
Q4 2019 Feb 07, 2020	SELL	$19.53 - $25.5 $11,776 - $15,376	-603 Closed	0 $0
Q3 2019 Nov 05, 2019	BUY	$18.62 - $24.51 $11,227 - $14,779	603 New	603 $13,000
Q2 2019 Aug 13, 2019	SELL	$21.11 - $28.48 $23,115 - $31,185	-1,095 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$24.76 - $31.66 $21,268 - $27,195	859 Added 363.98%	1,095 $30,000
Q4 2018 Feb 14, 2019	BUY	$24.11 - $31.34 $4,508 - $5,860	187 Added 381.63%	236 $7,000
Q3 2018 Nov 13, 2018	SELL	$26.99 - $35.85 $10,121 - $13,443	-375 Reduced 88.44%	49 $1,000
Q2 2018 Aug 15, 2018	BUY	$17.02 - $35.2 $544 - $1,126	32 Added 8.16%	424 $13,000
Q1 2018 May 15, 2018	BUY	$19.9 - $32.25 $7,800 - $12,642	392 New	392 $8,000

Others Institutions Holding RYTM

# of Institutions

193

Shares Held

67.1M

Call Options Held

834K

Put Options Held

78.6K

View Full List

About RHYTHM PHARMACEUTICALS, INC.

Ticker RYTM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,720,000
Market Cap $3.3B
Description
Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of rare genetic diseases of obesity. The company's lead product candidate is IMCIVREE, a potent melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convert...

More about RYTM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Account

Tower Research Capital LLC (Trc) Rhythm Pharmaceuticals, Inc. Transaction History